4393 related articles for article (PubMed ID: 6589433)
1. Correlation of cytotoxicity with elimination of iodine-125 from nude mice inoculated with prelabeled human melanoma cells.
Lockshin A; Giovanella BC; Quian C; Mendoza JT; Vardeman DM; Stehlin JS
J Natl Cancer Inst; 1984 Aug; 73(2):417-22. PubMed ID: 6589433
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of anticancer drugs determined in nude mice inoculated with [125I]5-iodo-2'-deoxyuridine-prelabeled human melanoma cells.
Lockshin A; Giovanella BC; Vardeman DM; Mendoza JT; Quian C; Kozielski T; Stehlin JS
J Natl Cancer Inst; 1985 Apr; 74(4):899-903. PubMed ID: 3921748
[TBL] [Abstract][Full Text] [Related]
3. In vivo cytotoxicity assays with 111In-labeled tumor cells: comparison with [125I]iododeoxyuridine-labeled cells and effects of chelators and inoculation site.
Lockshin A; Kozielski T; Stehlin JS
Int J Rad Appl Instrum B; 1987; 14(5):515-21. PubMed ID: 3117739
[TBL] [Abstract][Full Text] [Related]
4. Determination of cytotoxicity in vivo using 111indium-labeled human tumor cells.
Lockshin A; Giovanella BC; Kozielski T; Stehlin JS
Cancer Lett; 1984 Sep; 24(2):179-85. PubMed ID: 6434180
[TBL] [Abstract][Full Text] [Related]
5. Unlabelled iododeoxyuridine increases the rate of uptake of [125I]iododeoxyuridine in human xenografted glioblastomas.
Dupertuis YM; Xiao WH; De Tribolet N; Pichard C; Slosman DO; Bischof Delaloye A; Buchegger F
Eur J Nucl Med Mol Imaging; 2002 Apr; 29(4):499-505. PubMed ID: 11914888
[TBL] [Abstract][Full Text] [Related]
6. Fluorodeoxyuridine improves imaging of human glioblastoma xenografts with radiolabeled iododeoxyuridine.
Dupertuis YM; Vazquez M; Mach JP; De Tribolet N; Pichard C; Slosman DO; Buchegger F
Cancer Res; 2001 Nov; 61(21):7971-7. PubMed ID: 11691821
[TBL] [Abstract][Full Text] [Related]
7. Monoclonal antibody and an antibody-toxin conjugate to a cell surface proteoglycan of melanoma cells suppress in vivo tumor growth.
Bumol TF; Wang QC; Reisfeld RA; Kaplan NO
Proc Natl Acad Sci U S A; 1983 Jan; 80(2):529-33. PubMed ID: 6572905
[TBL] [Abstract][Full Text] [Related]
8. Preclinical evaluation of locoregional delivery of radiolabeled iododeoxyuridine and thymidylate synthase inhibitor in a hepatoma model.
Chi KH; Wang HE; Chen FD; Chao Y; Liu RS; Chou SL; Wang YS; Yen SH
J Nucl Med; 2001 Feb; 42(2):345-51. PubMed ID: 11216535
[TBL] [Abstract][Full Text] [Related]
9. Interleukin 1-induced augmentation of experimental metastases from a human melanoma in nude mice.
Giavazzi R; Garofalo A; Bani MR; Abbate M; Ghezzi P; Boraschi D; Mantovani A; Dejana E
Cancer Res; 1990 Aug; 50(15):4771-5. PubMed ID: 2196116
[TBL] [Abstract][Full Text] [Related]
10. Isolation of mouse stromal cells associated with a human tumor using differential diphtheria toxin sensitivity.
Arbiser JL; Raab G; Rohan RM; Paul S; Hirschi K; Flynn E; Price ER; Fisher DE; Cohen C; Klagsbrun M
Am J Pathol; 1999 Sep; 155(3):723-9. PubMed ID: 10487830
[TBL] [Abstract][Full Text] [Related]
11. Exceptional lethality for nude mice of cells derived from a primary human melanoma.
Lockshin A; Giovanella BC; De Ipolyi PD; Williams LJ; Mendoza JT; Yim SO; Stehlin JS
Cancer Res; 1985 Jan; 45(1):345-50. PubMed ID: 3965144
[TBL] [Abstract][Full Text] [Related]
12. The preparation of clinical grade 5-[123I]iodo-2'-deoxyuridine and 5-[125I]iodo-2'-deoxyuridine with high in vitro stability and the potential for early proliferation scintigraphy.
Schaffland AO; Delaloye AB; Kosinski M; Dupertuis YM; Buchegger F
Nucl Med Commun; 2004 May; 25(5):461-8. PubMed ID: 15100504
[TBL] [Abstract][Full Text] [Related]
13. Analysis of 5-iodo-2'-deoxyuridine incorporation in murine melanoma for photon activation therapy.
Laster BH; Popenoe EA; Wielopolski L; Commerford SL; Gahbauer R; Goodman J; Meek A; Fairchild RG
Radiother Oncol; 1990 Oct; 19(2):169-78. PubMed ID: 2255770
[TBL] [Abstract][Full Text] [Related]
14. Radiolabeled alpha(v)beta3 integrin antagonists: a new class of tracers for tumor targeting.
Haubner R; Wester HJ; Reuning U; Senekowitsch-Schmidtke R; Diefenbach B; Kessler H; Stöcklin G; Schwaiger M
J Nucl Med; 1999 Jun; 40(6):1061-71. PubMed ID: 10452325
[TBL] [Abstract][Full Text] [Related]
15. Biological behavior of malignant melanoma cells correlated to their survival in vivo.
Fidler IJ
Cancer Res; 1975 Jan; 35(1):218-24. PubMed ID: 1109790
[TBL] [Abstract][Full Text] [Related]
16. Anti-transferrin receptor monoclonal antibody and toxin-antibody conjugates affect growth of human tumour cells.
Trowbridge IS; Domingo DL
Nature; 1981 Nov; 294(5837):171-3. PubMed ID: 6272120
[No Abstract] [Full Text] [Related]
17. Lack of correlation between natural killer activity and tumor growth control in nude mice with different immune defects.
Fodstad O; Hansen CT; Cannon GB; Statham CN; Lichtenstein GR; Boyd MR
Cancer Res; 1984 Oct; 44(10):4403-8. PubMed ID: 6467201
[TBL] [Abstract][Full Text] [Related]
18. Quantitative evaluation of anticancer agents against human melanoma cells implanted in nude mice.
Lockshin A; Giovanella BC; Stehlin JS
Exp Cell Biol; 1986; 54(3):149-54. PubMed ID: 3743866
[TBL] [Abstract][Full Text] [Related]
19. 111Indium labeling of cultured human tumor cells.
Lockshin A; Mendoza JT; Giovanella BC; Stehlin JS
Oncology; 1985; 42(5):322-7. PubMed ID: 3929199
[TBL] [Abstract][Full Text] [Related]
20. Heterogeneity in mouse seminal vesicle epithelial cells responding to androgen as evaluated by incorporation of [125I]iododeoxyuridine.
Terada N; Ogasawara Y; Yamane T; Matsumoto K; Kitamura Y
Endocrinology; 1985 Apr; 116(4):1466-72. PubMed ID: 3971923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
